Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia
Description
CONCLUSION: Our data reveal an increase of cellular and humoral immune response in CLL patients after fourth COVID-19 vaccination combined with SARS-CoV-2 infection, even in those undergoing B cell-depleting treatment. Patients with prior vaccination